COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF AN ASSISTED REPRODUCTIVE TECHNOLOGY PROGRAM DEPENDING ON AN OVULATION TRIGGER
- Авторлар: Eapen S.M1, Pavlovich S.V1,2, Mishieva N.G2, Abubakirov A.N2, Martazanova B.A2
-
Мекемелер:
- I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
- Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Шығарылым: № 6 (2017)
- Беттер: 99-103
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/329715
- ID: 329715
Дәйексөз келтіру
Аннотация
Толық мәтін
Авторлар туралы
S. Eapen
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Email: dr.snehaeapen@gmail.com
graduate student Moscow 119991, Bolshaya Pirogovskaya str. 2-4, Russia
S. Pavlovich
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia; Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: st.pavlovich@mail.ru
PhD, Associate Professor, Scientific Secretary Moscow 119991, Bolshaya Pirogovskaya str. 2-4, Russia; Moscow 117997, Ac. Oparina str. 4, Russia
N. Mishieva
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: nondoc555@mail.ru
MD, Senior researcher of 1st gynecology department Moscow 117997, Ac. Oparina str. 4, Russia
A. Abubakirov
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: nondoc555@yahoo.com
PhD, Head of 1st gynecology department Moscow 117997, Ac. Oparina str. 4, Russia
B. Martazanova
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: bellamart88@mail.ru
Research assistant Moscow 117997, Ac. Oparina str. 4, Russia
Әдебиет тізімі
- Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil. Steril. 2016; Sep 24. pii: S0015-0282(16)62781-
- Павлович С.В., Бурлев В.А. Сосудисто-эндотелиальный фактор роста в патогенезе синдрома гиперстимуляции яичников. Акушерство и гинекология. 2004; 2: 11-3.
- Papanikolaou E.G., Tournaye H., Verpoest W., Camus M, Vernaeve V., VanSteirteghem A., Devroey P. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum. Reprod. 2005; 20(3): 636-41.
- Engmann L., DiLuigi A., Schmidt D., Nulsen J., Maier D., Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil. Steril. 2008; 89(1): 84-91.
- Itskovitz J., Boldes R., Levron J., Erlik Y., Kahana L., Brandes J.M. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil. Steril. 1991; 56(2): 213-20.
- Мартазанова Б.А., Мишиева Н.Г., Левков Л.А., Грачева А.М., Богатырева Х.А., Ипен С.М., Лапина В.С., Абубакиров А.Н. Оптимизация программ экстракорпорального оплодотворения путем замены триггера овуляции. Акушерство и гинекология. 2015; 10: 73-80.
- Ипен С.М., Мишиева Н.Г., Мартазанова Б.А., Донцова Т.В., Павлович С.В. Выбор триггера овуляции для оптимизации программ экстракорпорального оплодотворения (обзор литературы). Гинекология. 2016; 18(1): 84-7.
- Youssef M.A., Van der Veen F., Al-Inany H.G., Mochtar M.H., Griesinger G., Nagi Mohesen M. et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles (Review). Cochrane Database Syst Rev. 2014; (10): CD008046. doi: 10.1002/14651858. CD008046.pub4.
- Humaidan P. Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study. Reprod. Biomed. Online. 2009; 18(5): 630-4.
- Humaidan P., Ejdrup Bredkjaer H., Westergaard L.G., Yding Andersen C. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertil. Steril. 2010; 93(3): 847-54.
- Shapiro B.S., Daneshmand S.T., Garner F.C., Aquirre M., Hudson C. Comparison of „triggers” using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin. Fertil. Steril. 2011; 95(8): 2715-17.
- Acevedo B., Gomez-Palomares J.L., Ricciarelli E., Hernández E.R. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Fertil. Steril. 2006; 86(6): 1682-7.
- Imbar T., Kol S., Lossos F., Bdolah Y., Hurwitz A., Haimov-Kochman R. Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support. Hum. Reprod. 2012; 27(3): 753-9.